e-learning
resources
Madrid 2019
Monday, 30.09.2019
Asthma treatment: cohorts and real-world studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of the use of oral corticosteroids in asthma – a 3-year analysis in Germany
M. Lommatzsch (Rostock, Germany), C. Wilmer (Nürnberg, Germany), I. Schwab Sauerbeck (Nürnberg, Germany)
Source:
International Congress 2019 – Asthma treatment: cohorts and real-world studies
Session:
Asthma treatment: cohorts and real-world studies
Session type:
Thematic Poster
Number:
2556
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lommatzsch (Rostock, Germany), C. Wilmer (Nürnberg, Germany), I. Schwab Sauerbeck (Nürnberg, Germany). Prevalence of the use of oral corticosteroids in asthma – a 3-year analysis in Germany. 2556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Oral corticosteroid prescription patterns in asthma care in Italy
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005
Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE)
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007
Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002
Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018
Year: 2019
12-year adherence to inhaled corticosteroids in adult-onset asthma
Source: ERJ Open Res, 6 (1) 00324-2019; 10.1183/23120541.00324-2019
Year: 2020
12-year adherence to inhaled corticosteroids in adult-onset asthma
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Suboptimal persistence with inhaled corticosteroid (ICS) mono-therapy among children with persistent asthma in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 709s
Year: 2006
Oral corticosteroid use in Swedish and Finnish severe asthma patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
The APEX study: A retrospective review of responses of severe allergic asthma patients to omalizumab on continuous or non-continuous oral corticosteroids in UK clinical practice
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007
The APEX study: Retrospective review of oral corticosteroid use in omalizumab-treated severe allergic asthma patients in UK clinical practice
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
How can we minimise the use of regular oral corticosteroids in asthma?
Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Year: 2020
Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003
Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept